Tuesday, December 9, 2014

The research may KTH giant donation – New Technology


     KTH Professor Mathias Uhlén unveiled the world’s first image atlas of which the body’s 20,000 proteins that are used to build all the organs and tissues of a healthy person. Now he and his team the largest donation in KTH’s history to research further. Photo: Jörgen Appelgren
     

The research will make it possible for us all to get the right medication at the right time has been one of the largest donations in KTH’s history.

(Updated). A month ago, KTH Professor Mathias Uhlén world’s first picture atlas of which the body’s 20,000 proteins that are used to build all the organs and tissues of a healthy person. The launch attracted worldwide attention. At the same time, researchers have come a long way with the corresponding image atlas of diseased tissues and organs. To take that knowledge to practical use in health care may Mathias Uhlén and his research team now has 90 million worth of family Ehrling-Persson Foundation. The donation is the largest donation in KTH’s history.

– What if in the future we can save lives through screening of the body biomarkers and in this way reduce suffering and earlier detection example, cardiovascular disease and cancer, says Stefan Persson, chairman of the Erling-Persson Family Foundation.

Biomarkers are changes in our bodies that reveal that we are affected by disease. These include protein troponin in the heart. If the heart muscle is damaged leaking blood. This means that a blood test can be used to make a diagnosis. Another biomarker is the prostate-specific protein PSA

The challenge linked to the donation is to find the right treatment to the right patient at the right time for the right price.

– The biomarkers improves patient safety. They enable doctors to earlier correct diagnosis, give the right treatment, avoid serious side effects and replace other methods of examination contrast x-ray, invasive procedures and tissue samples, says Mathias Uhlén at KTH.

The research takes place both at KTH, partly at the National Research Institute of Science for Life Laboratory in Solna. Here is established right now a world leading center for clinical Applied proteomics (the study of proteins). Together, researchers in engineering, biomedicine and clinics to generate new knowledge about proteins and how they can be used practically in health care.

– My vision is that we in ten years to be able to go to the health center and take a blood test to see if we have a treatable disease, long before we get symptoms, says Mathias Uhlén.

Peter Gudmundson, president of KTH, rejoice giant donation.

– Donations of this variety plays a major role in order to achieve long-term bold research initiatives with the potential to really make a difference, he said.

Follow New Technology on Facebook!

LikeTweet

No comments:

Post a Comment